{
  "ptid_time": "116_S_4338_2011-11-02",
  "img_path": "/data/qiuhui/data/adni/images/116_S_4338/2011-11-02/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 64,729 mm³, 37.7% above the reference mean. With a Z-score of 1.09 (86.3th percentile), this represents mild enlargement; whole brain volume measures 905,264 mm³, 12.0% below the reference mean. With a Z-score of -1.58 (5.7th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 80.5 years. Gender is Male. Education: 14 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Endocrine-Metabolic; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking. MMSE: 21.0. MoCA: 11.0. Logical Memory: 0.0. Laboratory findings: Monocytes: 0.63 (significant elevated); Total Bilirubin: 1.10 (profound elevated); Direct Bilirubin: 0.30 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.94 SUVR (mild reduced); Amyloid beta: 1452.00 pg/mL (mild elevated); Total tau: 321.00 pg/mL (mild elevated); Phosphorylated tau: 27.62 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows moderate whole brain atrophy and mild ventricular enlargement, along with cognitive scores (MMSE 21, MoCA 11) well below normal ranges for age. Mildly elevated Aβ and T-tau, along with reduced AV45 (amyloid PET), suggest early Alzheimer's pathology despite the absence of APOE4.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **Medium** (Cognitive scores strongly suggest dementia, but the absence of APOE4 and only mild biomarker abnormalities introduce some uncertainty.)",
  "timestamp": "2025-07-26T12:10:42.007744"
}